This antibody recognizes an extracellular domain of human CD152, an approximately 45 kDa type I transmembrane protein serving as a negative regulator of T cell responses.
Separation of human CD152 positive CD3 positive lymphocytes (red-filled) from CD152 negative CD3 negative lymphocytes (black-dashed) in flow cytometry surface staining of human peripheral whole blood, labeling CTLA4 with Anti-CTLA4 Antibody [BNI3] (A86438), (concentration in sample 10 µg/ml) GAM APC.
Publishing research using Anti-CTLA4 Antibody [BNI3] (A86438)? Please let us know so that we can list the citation on this page.
Alternative products to Anti-CTLA4 Antibody [BNI3] (A86438)
Recombinant human monoclonal antibody to CTLA-4 for use as a research grade Nurulimab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to CTLA-4 for use as a research grade Zalifrelimab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to CTLA-4 for use as a research grade Firastotug biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to CTLA-4 for use as a research grade Nurulimab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to CTLA-4 for use as a research grade Zalifrelimab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to CTLA-4 for use as a research grade Firastotug biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.